A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension.

James C. Coons,Karryn Crisamore,Solomon M. Adams,Ashley Modany,Marc A. Simon,Wenchen Zhao,Imam H. Shaik,Raman Venkataramanan,Philip E. Empey

A pilot study of oral treprostinil pharmacogenomics and treatment persistence in patients with pulmonary arterial hypertension.

2021

James C. Coons
Karryn Crisamore
Solomon M. Adams
Ashley Modany
Marc A. Simon
Wenchen Zhao
Imam H. Shaik
Raman Venkataramanan
Philip E. Empey

Background and aims:Treprostinil is a prostacyclin analog used to treat pulmonary arterial hypertension. Dosing is empiric and based on tolerability. Adverse effects are common and can affect treat...

Keywords:

Intensive care medicine
in patient
Pharmacogenomics
Prostacyclin
Personalized medicine
Treprostinil
Dosing
Medicine
Adverse effect
Tolerability

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations